Current
14.30 €
-0.69% today
Start price
15.20 €
Target price
–
End price
12.10 €
Performance (%)
-20.39%
Confidence
50%
Time horizon
2027-03-01
Performance since start
How it ranks
- #12 Rank 12 of 20 by performance
- 11 ratings for this instrument performed better
- 1 other running rating for this instrument
Summary
This prediction ended on 10.03.26 with a price of €12.10. The prediction for Theravance Biopharma closed with a convincing performance of -20.39%. Bankster has 50% into this prediction
Investment thesis
Pros and cons by Bankster
For
Against
Risky Investment
Timeline & discussion
Reasoning and updates for this rating
The discussion is visible to sharewise members.
2 comments are waiting for you.